VENTANA PD-L1 (SP263)

Rabbit Monoclonal Primary Antibody

PD-L1 analytic assay | Navigating the unknown

The VENTANA PD-L1 (SP263) Rabbit Monoclonal Primary Antibody empowers you to evaluate the expression of PD-L1 protein using the OptiView DAB IHC Detection Kit. Available for sale in the US and CE Marked.


PD-L1 diagnostic confidence

VENTANA PD-L1 (SP263) Rabbit Monoclonal Primary Antibody is intended for laboratory use in the detection of the PD-L1 protein in formalin-fixed, paraffin-embedded tissue. It is intended to be stained with BenchMark IHC/ISH instruments. It is indicated as an aid in the assessment of PD-L1 expression in human tissues

> See assay catalog


 

Related predictive PD-L1 assay

VENTANA PD-L1 (SP263) Assay

Related predictive assay

VENTANA PD-L1 (SP263) Assay guides immunotherapy decisions by identifying:

  • Non-small cell lung cancer (NSCLC) patients eligible for treatment with KEYTRUDA® (pembrolizumab) [CE mark only, not FDA approved]
  • Non-squamous NSCLC patients most likely to benefit from OPDIVO® (nivolumab) [CE mark only, not FDA approved]
  • Urothelial carcinoma (UC) patients most likely to benefit from IMFINZITM (durvalumab) [FDA approved in the US, CE mark]

> Learn more

Print:

 

The PD-L1 immunologic checkpoint

> Learn more


The tumor microenvironment